The British Medical Journal Open recently published a paper describing the study protocol for a cluster randomised controlled trial of the Mana Tū programme. Mana Tū is a unique Māori-lead programme developed and led by the NHC that supports people with poorly controlled type 2 diabetes to successfully self-manage with their condition.
Type 2 diabetes mellitus (T2DM) and its complications are more common among Māori and Pacific people compared with other ethnic groups in New Zealand. Comprehensive and sustained approaches that address social determinants of health are required to address this condition, including culturally specific interventions. Currently, New Zealand has no comprehensive T2DM management programme for Māori or Pacific people. Mana Tū is seeking to change that, by providing indigenous health worker support for whānau with poorly controlled type 2 diabetes.